Imaging, biopsy often still needed after mastectomy

December 5, 2018

(HealthDay)—Subsequent imaging is required for 10 to 15.5 percent of women who undergo mastectomy, according to a study published in the December issue of the Annals of Surgical Oncology.

Soojin Ahn, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues conducted a retrospective review of all unilateral mastectomy (UM) and bilateral mastectomy (BM) cases managed at a single institution between 2009 and 2015.

The researchers identified 185 UM and 200 BM cases managed for breast cancer. Patients were followed for a mean of 30 months. Of the 185 UM patients, 10, 6, and 1 percent underwent ipsilateral imaging for physical examination findings, underwent , and had malignant findings, respectively. Of the 200 BM patients, 15.5 percent required imaging; 76 percent of the ultrasounds were performed on the side with previous cancer. Eight percent of the BM subsequently had biopsy; 69 percent of these biopsies were performed on the ipsilateral side. Overall, 1.5 percent of the biopsies on the ipsilateral side were malignant, while the contralateral biopsies were all benign.

"Given the extent to which the avoidance of future imaging plays a role in decision making by a subset of women who opt for , this information is critical for patient understanding and for establishing reasonable postoperative expectations regarding the potential need for future imaging, even with UM or BM," the authors write.

Explore further: Future breast imaging and biopsy are not eliminated after mastectomy

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Future breast imaging and biopsy are not eliminated after mastectomy

October 9, 2018
The proportion of breast cancer patients who are eligible for breast conservation therapy, yet opt for mastectomy, is increasing, for reasons that include the desire to eliminate future screening and/or biopsy of the remaining ...

Potential new surgical options for women with multiple ipsilateral breast cancer

July 12, 2018
A new multi-institutional clinical trial compared outcomes of women with multiple ipsilateral breast cancer, or more than one site of disease in the same breast, who underwent breast-conserving surgery, with outcomes of those ...

Lumpectomy + radiation may cut breast cancer mortality in DCIS

August 20, 2018
(HealthDay)—Treatment with lumpectomy and radiotherapy is associated with a reduction in breast cancer mortality versus lumpectomy or mastectomy alone among patients with ductal carcinoma in situ (DCIS), according to a ...

FDA approves magnetic system for guiding lymph node biopsies

July 26, 2018
(HealthDay)—A magnetic system for guiding lymph node biopsies in patients with breast cancer undergoing mastectomy has been approved by the U.S. Food and Drug Administration.

Study evaluates need for biopsies during follow-up care in women with early breast cancer

January 31, 2018
In an analysis of more than 120,000 women diagnosed with and treated for early-stage breast cancer, researchers from The University of Texas MD Anderson Cancer Center determined the rate of additional breast biopsies needed ...

Complication rates low with mastectomy, breast reconstruction: study

September 2, 2014
(HealthDay)—Complications are rare among breast cancer patients who undergo mastectomy and reconstruction, a new study indicates.

Recommended for you

Pushing closer to a new cancer-fighting strategy

December 11, 2018
A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study. The ...

Scientists have identified and modelled a distinct biology for paediatric AML

December 11, 2018
Scientists have identified and modelled a distinct biology for paediatric acute myeloid leukaemia, one of the major causes of death in children.

HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer

December 11, 2018
Metastatic breast cancers treated with hormone therapy can become treatment-resistant when they acquire mutations in the human epidermal growth factor receptor 2 (HER2) that were not present in the original tumor, reports ...

Breast cancer drug could create chink in the armour of pancreatic cancer

December 11, 2018
The well-known drug tamoxifen could exploit a weakness in the physical 'scaffolds' around tumours, according to research led by Imperial.

Taking uncertainty out of cancer prognosis

December 11, 2018
A cancer diagnosis tells you that you have cancer, but how that cancer will progress is a terrifying uncertainty for most patients. Researchers at Cold Spring Harbor Laboratory (CSHL) have now identified a specific class ...

Loss of two genes drives a deadly form of colorectal cancer, reveals a potential treatment

December 11, 2018
Colorectal cancers arise from earlier growths, called polyps, found on the inner surface of the colon. Scientists are now learning that polyps use two distinct molecular pathways as they progress to cancer, called the "conventional" ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.